Big pharma stocks rise as Street reacts to latest presidential tariff plan

The president said late Thursday that he would place 100% import taxes on pharmaceuticals starting Oct. 1, but those tariffs would not apply to companies building U.S. manufacturing plants. He defined that as either “breaking ground” or being “under construction.” Several big drugmakers like Merck...

Redirecting to full article...